Community/Retail

Previous research indicates that probiotics decrease upper respiratory infections in healthy adults and children, but limited data exist on older, overweight, and people with obesity.

In March, the FDA approved dasiglucagon (Zegalogue) for the treatment of severe hypoglycemia in people with diabetes aged 6 years or older.

Pharmacists can help provide optimal health care to women to improve the quality of their lives by offering advice and education on important areas.

While the exact reason for the decreased immune response in middle-aged adults remains unclear, these findings suggest that this patient population may be continuously susceptible to the 3c2A H3N2 infection, even with immunization.

Lynlee Burton, head of the Center for Vaccines and Emerging Infectious Diseases at PRA Health Sciences, discusses how the pandemic has impacted the way the United States views the pharmacist within the immunization space.

Jay Lieberman, MD, a pediatric infectious disease specialist and the senior medical director of PRA Health Sciences, discusses how health care professionals should approach discussing issues around vaccine hesitancy with parents.

This month's featured products include dapagliflozin, naloxone hydrochloride spray, and short ragweed pollen allergen extract.

Susan Lang, CEO of XIL Health and former senior executive at Express Scripts, discusses some of the reimbursement issues that have been arising for pharmacies while administering COVID-19 vaccines.

In the 18th century, Franz Friedrich Anton Mesmer introduced the healing power of animal magnetism to Europe.

Lynlee Burton, head of the Center for Vaccines and Emerging Infectious Diseases at PRA Health Sciences, discusses the significance of short vaccine development timelines on the future development of COVID-19 vaccines.

Jay Lieberman, MD, a pediatric infectious disease specialist and the senior medical director of PRA Health Sciences, discusses his decision to enroll his twin daughters in the Moderna COVID-19 vaccine trial.

Susan Lang, CEO of XIL Health and former senior executive at Express Scripts, discusses the impact of declining reimbursements on pharmacies that were already hard hit by the COVID-19 pandemic.

Patients who added dupilumab to standard of care saw a 65% reduction in the rate of severe asthma attacks over 1 year.

Pharmacists should counsel patients periodically to ensure correct usage for better disease and treatment management.

The researchers analyzed immunization records for more than 300,000 Texas children from birth to 24 months.

David Silverstein, JD, MS, a partner in Axinn’s Intellectual Property Practice Group and FDA practice groups, discusses the challenges posed by the White House’s support for the proposal to the WTO to waive IP protections for COVID-19 vaccines.

Jay Lieberman, MD, a pediatric infectious disease specialist and the senior medical director of PRA Health Sciences, on the future of COVID-19 disease and vaccines for adolescents and children.

During a recent roundtable discussion, industry leaders shared frontline insights on the biggest drug diversion challenges.

most women reported 1 or more episodes of weight cycling, and each additional weight cycling episode was related to shorter sleep duration and poorer sleep quality.

Both strains of Influenza A for the northern hemisphere vaccines will be different from those included last season.

New research results show that over the next decade COVID-19 may be more like the common cold.

David Silverstein, JD, MS, a partner in Axinn’s Intellectual Property Practice Group and FDA practice groups, discusses the implications of the White House support for the proposal presented to the WTO to waive IP protections for COVID-19 vaccines.

No cases of COVID-19 were observed in the vaccine group using the case definition from the adult phase 3 COVE study, compared to 4 cases in the placebo group.

Pharmacy team members can provide educational resources, strategies to kids to promote safety.

A study published in Nature may document a previously unknown interaction between gut microbes and the thymus, an immune system organ.

High antibody levels were also generated in participants with evidence of a prior SARS-CoV-2 infection, suggesting that this could be developed as a booster.